Ampio seeks to reassure investors after drug freezing clouds trial

Ampio Pharmaceuticals Inc. is exploring what it can do with results from a 500-patient test of its experimental osteoarthritis drug after learning a contractor that handled shipping the medicine allowed more than 70 percent of it to get below freezing in transit...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.